Tight Sequestration of BH3 Proteins by BCL-xL at Subcellular Membranes Contributes to Apoptotic Resistance - Archive ouverte HAL Access content directly
Journal Articles Cell Reports Year : 2016

Tight Sequestration of BH3 Proteins by BCL-xL at Subcellular Membranes Contributes to Apoptotic Resistance

(1) , (1) , (1) , (1) , (1) , (1) , (2) , (3) , (1) , (2) , (3) , (4, 1) , (1, 4)
1
2
3
4
Laurent A Maillet

Abstract

Anti-apoptotic BCL-2 family members bind to BH3-only proteins and multidomain BAX/BAK to preserve mitochondrial integrity and maintain survival. Whereas inhibition of these interactions is the biological basis of BH3-mimetic anti-cancer therapy, the actual response of membrane-bound protein complexes to these compounds is currently ill-defined. Here, we find that treatment with BH3 mimetics targeting BCL-xL spares subsets of cells with the highest levels of this protein. In intact cells, sequestration of some pro-apoptotic activators (including PUMA and BIM) by full-length BCL-xL is much more resistant to derepression than previously described in cell-free systems. Alterations in the BCL-xL C-terminal anchor that impacts subcellular membrane-targeting and localization dynamics restore sensitivity. Thus, the membrane localization of BCL-xL enforces its control over cell survival and, importantly, limits the pro-apoptotic effects of BH3 mimetics by selectively influencing BCL-xL binding to key proapoptotic effectors.
Fichier principal
Vignette du fichier
CellRep2016Eq8.pdf (2.52 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

inserm-01416194 , version 1 (14-12-2016)

Identifiers

Cite

Jessie Pécot, Laurent A Maillet, Janic P Le Pen, Céline Vuillier, Sophie de Carné Trécesson, et al.. Tight Sequestration of BH3 Proteins by BCL-xL at Subcellular Membranes Contributes to Apoptotic Resistance. Cell Reports, 2016, ⟨10.1016/j.celrep.2016.11.064⟩. ⟨inserm-01416194⟩
266 View
174 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More